The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
SYNAGIS palivizumab (rmc) 50 mg / 0.5 mL solution for injection vial (231133)
ARTG Name
SYNAGIS palivizumab (rmc) 50 mg / 0.5 mL solution for injection vial
Product name
SYNAGIS palivizumab (rmc) 50 mg / 0.5 mL solution for injection vial
ARTG Date
Registration Type
Medicine
Therapeutic good type
Medicine
Sponsor
Ingredients
Palivizumab
Licence category
RE
Licence status
A
Summary
Product Information
Consumer Medicine Information